# OnCo record paper-lenalidomide-multiple-myeloma-n-engl-j-med-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lenalidomide-multiple-myeloma-n-engl-j-med-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lenalidomide-multiple-myeloma-n-engl-j-med-2016" ;
  schema:name "Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma"@en ;
  schema:description "Phase 2 or 3 results paper on Lenalidomide in Multiple myeloma, in New England Journal of Medicine (2016), one of the most cited Europe PMC records with Lenalidomide in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-lenalidomide-multiple-myeloma-n-engl-j-med-2016/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1607751>, <https://pubmed.ncbi.nlm.nih.gov/27705267/>, <https://europepmc.org/article/MED/27705267> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1607751> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Dimopoulos MA, Oriol A, Nahi H, et al." ;
  onco:journals <https://onco.cc/journals/nejm/> .